Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDVirax Biolabs Group Limited Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.33 | -$0.33 | -$0.33 |
| Q2 2025 | 1 | -$0.34 | -$0.34 | -$0.34 |
| Q3 2025 | 1 | -$0.34 | -$0.34 | -$0.34 |
| Q4 2025 | 1 | -$0.23 | -$0.23 | -$0.23 |
Virax Biolabs Group Limited Earnings Date And Information
Virax Biolabs Group Limited last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 1.38 K for the quarter and had revenue of 6.33 K for the year. Virax Biolabs Group Limited has generated $-2 earnings per share over the last year ($-1.95 diluted earnings per share) and currently has a price-to-earnings ratio of -0.45. Virax Biolabs Group Limited has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Saturday, November 1st, 2025 based on prior year's report dates.
Virax Biolabs Group Limited Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 07/02/2025 | Q4 2025 | N/A | -$0.76 | N/A | $10.00 K | $1.38 K |
| 11/20/2024 | Q2 2025 | N/A | -$0.89 | N/A | $4.95 K | $4.95 K |
| 08/20/2024 | Q4 2024 | N/A | -$1.71 | N/A | $79.92 K | $79.92 K |
| 09/29/2023 | Q2 2024 | N/A | -$1.64 | N/A | N/A | $76.50 K |
| 03/31/2023 | Q4 2023 | N/A | -$2.58 | N/A | N/A | $2.80 K |
| 09/29/2022 | Q2 2023 | N/A | -$1.24 | N/A | N/A | $5.76 K |
| 08/12/2022 | Q4 2022 | N/A | -$1.02 | N/A | N/A | $-92,865 |
| 09/29/2021 | Q2 2022 | N/A | -$0.49 | N/A | N/A | $0 |
| 03/30/2021 | Q4 2021 | N/A | -$0.27 | N/A | N/A | $109.82 K |
| 09/29/2020 | Q2 2021 | N/A | -$0.30 | N/A | N/A | $14.00 K |
| 03/30/2020 | Q4 2020 | N/A | -$0.02 | N/A | N/A | $24.97 K |
| 09/30/2019 | Q2 2020 | N/A | -$0.68 | N/A | N/A | $74.91 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Virax Biolabs Group Limited Earnings: FAQ's
Virax Biolabs Group Limited has not confirmed its next earnings publication date, but the company's estimated earnings date is Saturday, November 1st, 2025 based offlast year's report dates.
The conference call for Virax Biolabs Group Limited's latest earnings report can be listened to online.
The conference call transcript for Virax Biolabs Group Limited's latest earnings report can be read online.
Virax Biolabs Group Limited (:VRAX) has a recorded annual revenue of $6.33 K.
Virax Biolabs Group Limited (:VRAX) has a recorded net income of $-6,061,247.Virax Biolabs Group Limited has generated $-1.96 earnings per share over the last four quarters.
Virax Biolabs Group Limited (:VRAX) has a price-to-earnings ratio of -0.45 and price/earnings-to-growth ratio is -0.01.